---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-260160"
form_type: "8-K"
ticker: "OFIX"
cik: "0000884624"
company_name: "Orthofix Medical Inc."
filed_at: "2022-10-11T23:59:59+00:00"
generated_at: "2026-06-23T04:36:45.507770+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Orthofix reports Q3 preliminary net sales $114M, up 5% CC; announces SeaSpine merger

## Summary
- Preliminary Q3 net sales $114M, +1% reported, +5% constant currency YoY; nine-month net sales $339M, flat reported.
- Global Orthopedics grew 19% CC; Biologics +8% CC; Bone Growth Therapies +3% CC; Spinal Implants -7% CC.
- Preliminary cash, cash equivalents and restricted cash ~$52M as of Sep 30, 2022.
- Entered all-stock merger of equals with SeaSpine (NASDAQ: SPNE) to create leading spine and orthopedics company.

## SEC filing metadata
- accession: 0001193125-22-260160
- form_type: 8-K
- ticker: OFIX
- cik: 0000884624
- company_name: Orthofix Medical Inc.
- filed_at: 2022-10-11T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/884624/000119312522260160/0001193125-22-260160-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/884624/000119312522260160/d407558d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-260160
- JSON: https://secwatch.observer/filing/0001193125-22-260160.json
- Plain text: https://secwatch.observer/filing/0001193125-22-260160.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.